EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access

Remote Screening for Asymptomatic Atrial Fibrillation

Rohan Wijesurendra, Guilherme Pessoa-Amorim, Georgina Buck, Charlie Harper, Richard Bulbulia, Alison Offer, Nicholas R Jones, Christine A'Court, Rijo Kurien, Karen Taylor, Barbara Casadei, Louise Bowman

JAMA · 21.10.2025 · 334 (15) · 1349

DOI: 10.1001/jama.2025.15440 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JAMA, erschienen am 21.10.2025. Verfasst von Rohan Wijesurendra und 11 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Trial Service Unit and Epidemiological Studies Unit, Oxford Population Health, University of Oxford, Oxford, United Kingdom. Hauptthemen laut MEDLINE: Atrial Fibrillation, Electrocardiography, Ambulatory, Mass Screening. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Screening for atrial fibrillation (AF) might reduce stroke if it increases long-term AF detection and anticoagulation use compared with usual care.

Objective

To investigate the long-term efficacy of AF screening in older individuals at moderate to high risk of stroke using 14-day, patch-based continuous ambulatory electrocardiogram (ECG) monitoring. Design, Setting, and Participants A parallel-group, unblinded, remote randomized clinical trial recruiting from 27 UK primary care practices from May 2, 2019, to February 28, 2022. All eligible individuals 65 years or older with a CHA 2 DS 2 VASc score of 3 or higher (men) or 4 or higher (women) with no previous AF or atrial flutter were identified via automated electronic health record searches. Last follow-up was on August 29, 2024, and statistical analysis was conducted from May to July 2025.

Intervention

Participants were randomized to receive and return an ECG patch monitor by postal mail (intervention, n = 2520) or usual care (control, n = 2520). Main Outcomes and Measures Intention-to-treat analysis of the proportion of participants with AF recorded in primary care records within 2.5 years postrandomization. Exploratory outcomes included exposure to oral anticoagulation and stroke.

Results

Of the 22 044 individuals invited, 5040 (22.9%) were randomized. The participants’ mean (SD) age was 78 (6) years, 47% were female, and the median (IQR) CHA 2 DS 2 VASc score was 4 (3-5). A total of 2126 participants (84.4%) wore and returned the patch. AF was detected by patch in 89 participants (4.2%), 55% of whom had an AF burden less than 10%. After 2.5 years, a postrandomization record of AF was present in 172 individuals (6.8%) in the intervention group vs 136 (5.4%) in the control group (ratio of proportions, 1.26 [95% CI, 1.02-1.57]; P = .03), with consistent results in prespecified subgroups. Mean exposure to oral anticoagulation by 2.5 years was 1.63 months (95% CI, 1.50-1.76) in the intervention group and 1.14 months (95% CI, 1.01-1.26) in the control group (difference, 0.50 months [95% CI, 0.24-0.75]; P < .001). Stroke occurred in 69 participants (2.7%) in the intervention group and 64 (2.5%) in the control group (rate ratio, 1.08 [95% CI, 0.76-1.53]). Conclusions and Relevance In this remote randomized clinical trial, mail-based AF screening with an ECG patch in older patients at moderate to high risk of stroke led to a modest long-term increase in AF diagnosis at 2.5 years. Trial Registration ISRCTN Identifier: 15544176

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationElectrocardiography, AmbulatoryMass ScreeningAgedAged, 80 and overFemaleHumansMaleAnticoagulantsAsymptomatic DiseasesIntention to Treat AnalysisPrimary Health CareStrokeFollow-Up StudiesAdministration, Oral

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Clinical Trial Service Unit and Epidemiological Studies Unit, Oxford Population Health, University of Oxford, Oxford, United Kingdom.
  • Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
  • National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, United Kingdom.

Zitieren

APA

Wijesurendra, R., Pessoa-Amorim, G., Buck, G., Harper, C., Bulbulia, R., Offer, A., Jones, N. R., A'Court, C., Kurien, R., Taylor, K., Casadei, B., & Bowman, L. (2025). Remote Screening for Asymptomatic Atrial Fibrillation. JAMA, 334(15), 1349. https://doi.org/10.1001/jama.2025.15440

Vancouver

Wijesurendra R, Pessoa-Amorim G, Buck G, Harper C, Bulbulia R, Offer A, et al. Remote Screening for Asymptomatic Atrial Fibrillation. JAMA. 2025;334(15):1349. doi:10.1001/jama.2025.15440

BibTeX
@article{Wijesurendra2025,
  author = {Wijesurendra, Rohan and Pessoa-Amorim, Guilherme and Buck, Georgina and Harper, Charlie and Bulbulia, Richard and Offer, Alison and Jones, Nicholas R and A'Court, Christine and Kurien, Rijo and Taylor, Karen and Casadei, Barbara and Bowman, Louise},
  title = {Remote Screening for Asymptomatic Atrial Fibrillation},
  journal = {JAMA},
  year = {2025},
  volume = {334},
  number = {15},
  pages = {1349},
  doi = {10.1001/jama.2025.15440}
}
Kostenlos starten →